Next report date
Report period
Q2 2024
EPS estimate
0.32EUR
Revenue estimate
1.66 BEUR
1.21EUR
2.09 BEUR
7.14 BEUR
610.28 M
About CHUGAI PHARMACEUTICAL CO
Sector
CEO
Osamu Okuda
Headquarters
Tokyo
Website
Employees (FY)
7.6 K
Founded
1925
ISIN
JP3519400000
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
4519:TSE - CHUGAI PHARMACEUTICAL - Up 145% over 12 months.Japanese listed Chugai Pharmaceutical is in a nice steady up trend. Could be worth a watch.
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business
4519, Chugai Pharmaceutical Co. - Trailing StopTSE:4519
The upward trend of one of our trades in the Japanese market continues.
We follow as always the not realized profit by ensuring more and more a Risk Reward as optimal as possible.
Good trading at all!
4519, Chugai Pharmaceutical Co. - Breakout on ascending triangleTSE:4519
Net breakout of the resistance of this ascending triangle.
As always, one of the parameters for deciding whether or not to enter our trade is the Yield Risk ratio, in which winning trades allow us both to compensate for the small losses we make 60% of the time and to create that extra marg
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CUP is 28.90 EUR — it has decreased by 0.76% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CHUGAI PHARMACEUTICAL CO LTD stocks are traded under the ticker CUP.
CHUGAI PHARMACEUTICAL CO LTD is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
CUP stock is 1.35% volatile and has beta coefficient of 0.95. Check out the list of the most volatile stocks — is CHUGAI PHARMACEUTICAL CO LTD there?
CUP earnings for the last quarter are 0.36 EUR per share, whereas the estimation was 0.33 EUR resulting in a 9.18% surprise. The estimated earnings for the next quarter are 0.29 EUR per share. See more details about CHUGAI PHARMACEUTICAL CO LTD earnings.
CHUGAI PHARMACEUTICAL CO LTD revenue for the last quarter amounts to 1.76 B EUR despite the estimated figure of 1.83 B EUR. In the next quarter revenue is expected to reach 1.49 B EUR.
Yes, you can track CHUGAI PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
CUP stock has fallen by 4.65% compared to the previous week, the month change is a 20.17% fall, over the last year CHUGAI PHARMACEUTICAL CO LTD has showed a 25.65% increase.
CUP net income for the last quarter is 455.58 M EUR, while the quarter before that showed 585.62 M EUR of net income which accounts for −22.21% change. Track more CHUGAI PHARMACEUTICAL CO LTD financial stats to get the full picture.
Today CHUGAI PHARMACEUTICAL CO LTD has the market capitalization of 47.82 B, it has decreased by 0.05% over the last week.
CHUGAI PHARMACEUTICAL CO LTD dividend yield was 1.50% in 2023, and payout ratio reached 40.44%. The year before the numbers were 2.32% and 34.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, CUP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHUGAI PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 7.60 K employees. See our rating of the largest employees — is CHUGAI PHARMACEUTICAL CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHUGAI PHARMACEUTICAL CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHUGAI PHARMACEUTICAL CO LTD stock shows the neutral signal. See more of CHUGAI PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CHUGAI PHARMACEUTICAL CO LTD future price: according to them, CUP price has a max estimate of 44.38 EUR and a min estimate of 26.95 EUR. Read a more detailed CHUGAI PHARMACEUTICAL CO LTD forecast: see what analysts think of CHUGAI PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHUGAI PHARMACEUTICAL CO LTD EBITDA is 2.61 B EUR, and current EBITDA margin is 40.26%. See more stats in CHUGAI PHARMACEUTICAL CO LTD financial statements.